Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.60 Average Target Price from Brokerages
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has received a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price objective among analysts […]
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has received a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price objective among analysts […]
